Member Info for ogm4

Hats off to you Manlord! Great piece of work.

Hadn't noticed your posts as I was travelling in between from summer holidays in Greece straight back to work.

The market is about speed, efficiency and cost reduction.

Soon also the NHS will recognize this as they have limited budgets.

Https://x.com/genedriveplc/status/1819402011009331552

And indeed that's perfectly fine. We don't need Peel Hunt. This is about Genedrive and the global markets about to be unlocked after the recent milestones being achieved.

Interesting read on global stroke figures:

https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke

Today's world is all about achieving low-cost efficiency and speed. Lengthy and costly lab tests do not fall into that category imo.

Https://www.dailymail.co.uk/money/markets/article-13694629/MARKET-REPORT-City-duo-team-inject-20bn-UK-start-ups.html

Scroll bit down below

Today marks a fundamental day in the company's existence.

I can't wait until the next commercial orders are coming in both domestic and overseas.

1 hr ago

"Genedrive are thrilled to announce that NICE have recommended the Genedrive CYP2C19 ID Kit!"

https://x.com/genedriveplc/status/1818567601217221027

James Cheek, CEO of genedrive plc, said: "We are delighted with this final guidance from NICE recommending implementation of CYP2C19 genotype-guided use of Clopidogrel in IS and TIA patients in the NHS to reduce risk of recurrent strokes, and recommendation of our CYP2C19 ID-kit as the point-of-care interventional platform of choice. This represents a key milestone in our commercialisation plans for the product, and further solidifies our business strategy of leading provision of cost-effective solutions for pharmacogenetics in time critical emergency healthcare situations. We are proud to be at the forefront of the emergence of near-patient genetic testing in emergency healthcare to facilitate optimal personalised therapeutic choices and ultimately improve patient outcomes."

And there is the final RNS anticipated by so many!

Another one out this morning:

https://x.com/Empiremetalsltd/status/1817800372875940205

5 hrs ago

https://x.com/Empiremetalsltd/status/1816718243689538014

Good morning folks, let's see what today brings.

I feel this company is on the verge of an important breakthrough on two main developments.

No signs (yet) of any further delay

The US market is huge, make no mistake.

Especially interesting if GDR supplies products they don't have locally. Personally I guess 60-70% chance this company will be taken over within 3-4 years, but I could be wrong.

Even more chances now GDR will be taken over in the future by one of the US pharma majors imo.

Transformational month for Genedrive

*** FDA designation MT-RNR1 ****

Wow! This is getting better and better!....

James Cheek, CEO of genedrive plc, said: "We are delighted to receive FDA designation of our MT-RNR1 point of care pharmacogenetic test and corresponding recognition of the potential benefits to U.S. patients.

If CYP2C19 materializes this would be big news, if that would happen as a result I expect at least a JV partnership with one of the big pharmas to further develop and monitize. The global markt is huge and ties in with cost savings efforts on the prevention side.